Literature DB >> 20187261

Rasagiline in Parkinson's disease.

Michael A Schwarzschild.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20187261

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

Review 1.  Oxidative stress in neurodegenerative diseases: mechanisms and therapeutic perspectives.

Authors:  Ailton Melo; Larissa Monteiro; Rute M F Lima; Diêgo M de Oliveira; Martins D de Cerqueira; Ramon S El-Bachá
Journal:  Oxid Med Cell Longev       Date:  2011-11-24       Impact factor: 6.543

2.  MAO-inhibitors in Parkinson's Disease.

Authors:  Peter Riederer; Gerd Laux
Journal:  Exp Neurobiol       Date:  2011-03-31       Impact factor: 3.261

3.  Monoamine oxidase-B (MAO-B) inhibitors: implications for disease-modification in Parkinson's disease.

Authors:  Kay Cheong Teo; Shu-Leong Ho
Journal:  Transl Neurodegener       Date:  2013-09-08       Impact factor: 8.014
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.